share_log
Reuters ·  Apr 29 08:30
Monte Rosa Therapeutics Inc : UBS Cuts Target Price to $20 From $22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment